Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Varenicline and Nicotine Interactions in Humans (VA)

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Drug: Varenicline
Drug: Placebo
Drug: IV Nic

First Posted Date: 2008-02-05

Last Posted Date: 2014-09-25

Lead Sponsor: Yale University

Target Recruit Count: 37

Registration Number: NCT00606892

Locations: 🇺🇸
Veterans Affairs Hospital, West Haven, Connecticut, United States

Atomoxetine Effects in Humans

Phase 1

Completed

Conditions: Physiological Stress

Interventions: Drug: Atomoxetine

First Posted Date: 2008-02-05

Last Posted Date: 2011-12-12

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT00607568

Effectiveness of Cognitive Behavioral Therapy Plus Nutritional Counseling in Promoting Weight Loss in People With Binge Eating Disorder

Not Applicable

Completed

Conditions: Overweight
Binge Eating Disorder
Obesity

Interventions: Behavioral: Cognitive behavioral therapy plus general nutrition counseling (CBT+GN)
Behavioral: Cognitive behavioral therapy plus low energy density diet counseling (CBT+LED)

First Posted Date: 2008-01-28

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT00601653

Examining Heart Attacks in Young Women

Completed

Conditions: Acute Myocardial Infarction

First Posted Date: 2008-01-18

Last Posted Date: 2020-03-30

Lead Sponsor: Yale University

Target Recruit Count: 2985

Registration Number: NCT00597922

Locations: 🇺🇸
Saddleback Memorial Medical Center, Laguna Hills, California, United States
🇺🇸
Providence Hospital, Mobile, Alabama, United States
🇺🇸
Sharp Gross Hospital, La Mesa, California, United States

and more 89 locations

Cranberry for UTI Prevention in Residents of Long Term Care Facilities

Not Applicable

Completed

Conditions: Urinary Tract Infection

Interventions: Dietary Supplement: Once Daily Cranberry Capsule
Dietary Supplement: Twice Daily Cranberry Capsules

First Posted Date: 2008-01-17

Last Posted Date: 2013-03-29

Lead Sponsor: Yale University

Target Recruit Count: 56

Registration Number: NCT00596635

Locations: 🇺🇸
Yale University School of Medicine, Internal Medicine, Section of Infectious Diseases, New Haven, Connecticut, United States

Counseling for Primary Care Office-based Buprenorphine

Phase 4

Completed

Conditions: Opiate Dependence

Interventions: Behavioral: Manual-guided Physician Management (PM)
Behavioral: Physician Management (PM) combined with on-site manual-guided Cognitive Behavioral Therapy (CBT)

First Posted Date: 2008-01-16

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 141

Registration Number: NCT00595764

Locations: 🇺🇸
The APT Foundation, Inc. -- Welch Building, New Haven, Connecticut, United States
🇺🇸
Yale New Haven Hospital Primary Care Center, New Haven, Connecticut, United States

Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.

Phase 2

Completed

Conditions: Cocaine Dependence
Opioid Dependence

Interventions: Drug: levetiracetam

First Posted Date: 2008-01-14

Last Posted Date: 2017-01-12

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT00593125

Locations: 🇺🇸
VA CT Healthcare System, West Haven, Connecticut, United States

Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Dietary Supplement: Medium chain fatty acid (Octanoic and Decanoic acid)
Other: Splenda (Placebo Control)

First Posted Date: 2008-01-11

Last Posted Date: 2015-01-22

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT00592072

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes Mellitus

Completed

Conditions: Diabetes Mellitus, Type 1

First Posted Date: 2008-01-11

Last Posted Date: 2011-10-27

Lead Sponsor: Yale University

Target Recruit Count: 36

Registration Number: NCT00590876

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities

Terminated

Conditions: Glioblastoma Multiforme

Interventions: Other: dynamic contrast enhanced magnetic resonance imaging

First Posted Date: 2008-01-09

Last Posted Date: 2014-07-02

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT00589095

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy